Simeon George is Director at CRISPR Therapeutics AG (CRSP). They have made 12 open-market trades across 6 companies since 2014, most recently 2025-07-16.
CIK 0001595117
12 open-market purchases totalling $198.9M since 2014, never a sale. Across 12 scored buys the stock is up 4.5% at ninety days, and 1.2 points ahead of the S&P over the same stretch.
12 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 25% | 25% | 50% |
| Avg Move | -8.8% | -3.4% | +4.5% |
| Alpha | -8.4% | -3.6% | +1.2% |
| Scored | 12 | 12 | 12 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRSP | BUY | 2025-07-16 | 2025-07-17 | $52.03 | $103.0M | -0.3% | -2.8% | +21.3% |
| NKTX | BUY | 2024-03-27 | 2024-03-28 | $10.00 | $20.0M | -30.4% | -40.3% | -48.5% |
| DSGN | BUY | 2022-12-16 | 2022-12-20 | $8.42 | $14.8M | +8.6% | -6.9% | -27.6% |
| NKTX | BUY | 2022-04-28 | 2022-04-29 | $15.00 | $20.0M | -33.8% | -23.1% | -29.0% |
| DSGN | BUY | 2021-03-30 | 2021-04-01 | $20.00 | $5.0M | -22.7% | -8.4% | -33.7% |
| TPTX | BUY | 2020-05-21 | 2020-05-26 | $60.00 | $5.0M | -3.1% | +3.2% | +11.6% |
| PRNB | BUY | 2019-10-18 | 2019-10-22 | $28.00 | $10.0M | +13.2% | -1.3% | +91.5% |
| TPTX | BUY | 2019-09-10 | 2019-09-11 | $45.00 | $8.0M | -14.4% | -19.6% | +16.5% |
| TPTX | BUY | 2019-04-22 | 2019-04-24 | $18.00 | $5.8M | +19.8% | +45.3% | +38.9% |
| PRNB | BUY | 2018-09-18 | 2018-09-20 | $17.00 | $4.6M | -6.7% | -17.9% | -8.5% |
| CRSP | BUY | 2016-10-24 | 2016-10-26 | $14.00 | $931K | -1.7% | +31.9% | +22.5% |
| GNCA | BUY | 2014-02-10 | 2014-02-11 | $12.00 | $1.7M | -33.5% | -0.6% | -0.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.